ABOUT ML-210

Multi-goal agents are frequent in drug discovery and promiscuous multi-kinase inhibitors have proved therapeutically efficient anticancer medications; employing this for example, we propose that E7449 may possibly have enhanced or broader therapeutic performance by way of its dual PARP/TNKS inhibition.1 Chondrocytes are the key cells in cartilage a